Sanofi (SNY)
41.81
+0.48
(+1.16%)
USD |
NASDAQ |
Jun 25, 14:08
Sanofi Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2015 | 1.348B |
| December 31, 2014 | |
| December 31, 2013 | 1.696B |
| September 30, 2013 | 1.577B |
| March 31, 2013 | 1.528B |
| June 30, 2012 | 1.581B |
| Date | Value |
|---|---|
| June 30, 2011 | 1.744B |
| December 31, 2010 | 1.514B |
| December 31, 2009 | 1.785B |
| June 30, 2006 | 1.399B |
| March 31, 2006 | 1.261B |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| AstraZeneca PLC | 3.456B |
| GSK Plc | 2.045B |
| Johnson & Johnson | 3.495B |
| Eli Lilly & Co. | 3.51B |
| Merck & Co., Inc. | 11.98B |